Mark Chao, M.D., Ph.D.
Dr. Chao is currently the Chief Medical Officer of Scorpion Therapeutics and has over 20 years of experience in oncology research. He was most recently co-founder and CEO of TenSixteen Bio, a precision genomics therapeutics company. Previously, he served as VP in oncology clinical research at Gilead Sciences focused on early and late-stage clinical development. Prior to that, […]
Mark McCamish, M.D., Ph.D.
Dr. McCamish is President and Chief Executive Officer of IconOVir Bio. Previously he was President and Chief Executive Officer of Forty Seven, Inc. He led Forty Seven, Inc. during critical phases of clinical development to help patients defeat their cancer. This included growing from a valuation of $169 million as a private company through a […]